关注
necla öztaşkın
necla öztaşkın
Ataturk university, (Drug Design & Development Section)
在 atauni.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives
N Öztaşkın, Y Çetinkaya, P Taslimi, S Göksu, İ Gülçin
Bioorganic chemistry 60, 49-57, 2015
2192015
Synthesis, Antioxidant, and Antiacetylcholinesterase Activities of Sulfonamide Derivatives of Dopamine‐R elated Compounds
H Göçer, A Akıncıoğlu, N Öztaşkın, S Göksu, İ Gülçin
Archiv der pharmazie 346 (11), 783-792, 2013
1882013
Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes …
P Taslimi, HE Aslan, Y Demir, N Oztaskin, A Maraş, İ Gulçin, S Beydemir, ...
International journal of biological macromolecules 119, 857-863, 2018
1852018
Novel antioxidant bromophenols with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions
N Öztaskın, P Taslimi, A Maraş, İ Gülcin, S Göksu
Bioorganic chemistry 74, 104-114, 2017
1402017
The effects of some bromophenols on human carbonic anhydrase isoenzymes
P Taslimi, İ Gülçin, N Öztaşkın, Y Cetinkaya, S Göksu, SH Alwasel, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 31 (4), 603-607, 2016
1232016
Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes
Y Demir, P Taslimi, MS Ozaslan, N Oztaskin, Y Çetinkaya, İ Gulçin, ...
Archiv der pharmazie 351 (12), 1800263, 2018
992018
Synthesis and characterization of novel bromophenols: Determination of their anticholinergic, antidiabetic and antioxidant activities
N Öztaşkın, R Kaya, A Maraş, E Şahin, İ Gülcin, S Göksu
Bioorganic chemistry 87, 91-102, 2019
902019
Alternative and straightforward synthesis of dopaminergic 5-methoxy-1, 2, 3, 4-tetrahydronaphthalen-2-amine
N Öztaşkın, S Göksu, H Secen
Synthetic communications 41 (13), 2017-2024, 2011
282011
Diarilmetan compounds: discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia
P Taslimi, HE Aslan, Y Demir, N Oztaskin, A Maraş, İ Gulçin, S Beydemir, ...
Int J Biol Macromol 119, 857-863, 2018
12*2018
Synthesis of Novel Bromophenol with Diaryl Methanes—Determination of Their Inhibition Effects on Carbonic Anhydrase and Acetylcholinesterase
N Oztaskin, S Goksu, Y Demir, A Maras, İ Gulcin
Molecules 27 (21), 7426, 2022
112022
Synthesis and Characterisation of 2, 3, 4a, 6, 8a-penta-acetoxy decahydronaphthalene from 1, 2, 3, 4-tetrahydronaphthalen-2-ol
N Oztaskin, L Kelebekli, S Goksu, B Anil, E Sahin
Journal of Chemical Research 2009 (4), 231-233, 2009
32009
Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions
R El Ati, N Öztaşkın, A Çağan, A Akıncıoğlu, Y Demir, S Göksu, R Touzani, ...
Archiv der Pharmazie 357 (6), 2300545, 2024
12024
In silico and in vitro inhibition abilities of novel benzene sulfonamides on carbonic anhydrase and choline esterases
S Surgun, N Öztaşkın, A Çağan, A Akıncıoğlu, H Akıncıoğlu, S Göksu
Phosphorus, Sulfur, and Silicon and the Related Elements, 1-13, 2024
2024
Novel antioxidant bromophenols with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions
G Ilhami, P Taslimi, N Öztaşkın, S Göksu, A Maraş
Elsevier, 2017
2017
Dopamin Türevi Fenolik Sülfonamidlerin Sentezi ve Antioksidan Kapasitelerinin Belirlenmesi
H GÖÇER, A AKINCIOĞLU, N ÖZTAŞKIN, S GÖKSU, İ GÜLÇİN
系统目前无法执行此操作,请稍后再试。
文章 1–15